Rituxan (rituximab) - Roche
methotrexate - Generic mfg.
methotrexate IV - Generic mfg.
CD5-Positive Mature B-Cell Neoplasm With Large-Cell Morphology, Predominant Bone Marrow Involvement, and a Leukemic Peripheral Blood Presentation: A Case Report. (PubMed, Case Rep Hematol) - Oct 7, 2026 - "The patient received six cycles of R-CHOP followed by two cycles of systemic high-dose methotrexate as individualized central nervous system prophylaxis. A complete response was confirmed after treatment, with no evidence of recurrence 6 months after treatment completion." 
Journal • Diffuse Large B Cell Lymphoma • Hematological Disorders • Hematological Malignancies • Leukemia • Lymphoma • Oncology • BCL6 • CD5
http://www.ncbi.nlm.nih.gov/pubmed/42835947
 
Akari Yoda; Masamitsu Takaba; Shinya Fujisawa
 
Oct 7, 2026
 
Prev Next